News
New vaccinia-based COVID-19 vaccine candidate induces robust, durable immune responses
September 2021 Researchers in Australia have developed a coronavirus disease 2019 (COVID-9) vaccine that induced robust...
-
-
Report
$5.2 million raised to accelerate work on Australian Covid-19 vaccine
MEDIA RELEASE August 2021 Australian biotechnology company Sementis Limited has raised more than $5.2 million to accelerate...
-
News
Adelaide company Sementis will raise $10m to progress its Covid-19 vaccine candidate
August 2021 Adelaide biotech company Sementis is aiming to raise $10m to accelerate work on its next-generation Covid-19...
-
Report
Australia accelerates new COVID-19 vaccine to fight mutant strains
MEDIA RELEASE May 2021 A leading South Australian immunologist has been awarded $3 million from the Federal Government...
-
Report
New Director to Support COVID Vaccine Development at Sementis
April 2021 Adelaide-based Australian biotechnology company Sementis has appointed internationally-renowned Dr Anna...
-
Report
NHMRC Ideas Grant to support the development UniSA-Sementis peanut allergy vaccine
MEDIA RELEASE December 2020 Researchers at UniSA and Sementis are moving a step closer to developing a vaccine...
-
Report
UniSA helping to bring cheaper, needle-free, vaccines to the world
MEDIA RELEASE November 2018 In an international collaboration between Sementis and Enesi Pharma, Sementis...
-
News
Sementis and Enesi Pharma partner to develop needle-free vaccines
November 2018 Australian biotechnology firm Sementis has entered into a research and development (R&D) partnership...
-
News
UK pharma Enesi links with Australian biotech Sementis
November 2018 UK group Enesi Pharma has signed a deal with Australian biotech Sementis to develop solid dose versions...